Nuclear medical imaging for Parkinson’s disease

Nuclear medicine imaging enables early objectification of dopaminergic deficits and supports differential diagnosis. Imaging findings help with therapy planning, follow-up and individualization of treatment. Nuclear medicine procedures are a crucial addition to clinical Parkinson’s diagnostics. The article provides an overview of established tracers, their practical use and new developments that could enable earlier diagnosis and personalized therapy.